Literature DB >> 3541812

Pleural mesothelioma.

N Martini, P M McCormack, M S Bains, L R Kaiser, M E Burt, B S Hilaris.   

Abstract

Pleural mesotheliomas are uncommon tumors. Correct diagnosis of the benign variant is rarely made preoperatively, and resection is the treatment of choice and is curative. Malignant pleural mesotheliomas are locally aggressive and difficult to treat. They may be seen clinically as localized pleural tumors or as diffuse pleural disease with effusion and encasement of the lung and obliteration of the pleural space. The localized forms of malignant mesotheliomas are fibrosarcomatous. Their diagnosis and treatment do not differ from those for soft-part sarcomas seen elsewhere. Wide en-bloc excision is the treatment of choice and can be curative. The diffuse forms of malignant mesotheliomas are mainly epithelial. Treatment is generally unsatisfactory, and long-term survival is rare. Two surgical approaches are currently available: an extrapleural pneumonectomy and a pleurectomy with irradiation. The authors favor the latter approach because of its wider applicability, lower morbidity rate, and better survival advantage. Steps in selecting the best surgical mode of treatment are presented.

Entities:  

Mesh:

Year:  1987        PMID: 3541812     DOI: 10.1016/s0003-4975(10)60182-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

Review 1.  [Problems in diagnosis and therapy of malignant pleural mesothelioma].

Authors:  A Türler; S P Mönig; M Raab
Journal:  Med Klin (Munich)       Date:  1997-02-15

2.  Combinational therapy of crizotinib and afatinib for malignant pleural mesothelioma.

Authors:  Liyan Huang; Muyan Cai; Xu Zhang; Fang Wang; Likun Chen; Meng Xu; Ke Yang; Zhen Chen; Xiaokun Wang; Liwu Fu
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

3.  Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509.

Authors:  Linda L Garland; Kari Chansky; Antoinette J Wozniak; Anne S Tsao; Shirish M Gadgeel; Claire F Verschraegen; Marco A Dasilva; Mary Redman; David R Gandara
Journal:  J Thorac Oncol       Date:  2011-11       Impact factor: 15.609

4.  Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.

Authors:  S Cedrés; M A Montero; E Zamora; A Martínez; P Martínez; L Fariñas; A Navarro; D Torrejon; A Gabaldon; S Ramon Y Cajal; E Felip
Journal:  Clin Transl Oncol       Date:  2013-12-10       Impact factor: 3.405

5.  [Pleural mesothelioma--problems in diagnosis and clinical course in 25 patients].

Authors:  F Liewald; L Sunder-Plassmann; H Dienemann; J Mezger
Journal:  Langenbecks Arch Chir       Date:  1989

6.  Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma.

Authors:  Rong Liu; Aaron H Colby; Denis Gilmore; Morgan Schulz; Jialiu Zeng; Robert F Padera; Orian Shirihai; Mark W Grinstaff; Yolonda L Colson
Journal:  Biomaterials       Date:  2016-06-23       Impact factor: 12.479

Review 7.  Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival.

Authors:  E J Mark; D H Shin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 8.  Cerebral metastases in pleural mesothelioma: case report and review of the literature.

Authors:  M Wroński; M Burt
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

Review 9.  Fibrous tumors of the pleura.

Authors:  M de Perrot
Journal:  Curr Treat Options Oncol       Date:  2000-10

Review 10.  [Benign pleural mesothelioma. Report of 2 cases].

Authors:  S Ruff; M Dietrich; R Bähr
Journal:  Langenbecks Arch Chir       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.